Literature DB >> 2007583

Sodium-dependent nucleoside transport in mouse leukemia L1210 cells.

L Dagnino1, L L Bennett, A R Paterson.   

Abstract

Nucleoside permeation in L1210/AM cells is mediated by (a) equilibrative (facilitated diffusion) transporters of two types and by (b) a concentrative Na(+)-dependent transport system of low sensitivity to nitrobenzylthioinosine and dipyridamole, classical inhibitors of equilibrative nucleoside transport. In medium containing 10 microM dipyridamole and 20 microM adenosine, the equilibrative nucleoside transport systems of L1210/AM cells were substantially inhibited and the unimpaired activity of the Na(+)-dependent nucleoside transport system resulted in the cellular accumulation of free adenosine to 86 microM in 5 min, a concentration three times greater than the steady-state levels of adenosine achieved without dipyridamole. Uphill adenosine transport was not observed when extracellular Na+ was replaced by Li+, K+, Cs+, or N-methyl-D-glucammonium ions, or after treatment of the cells with nystatin, a Na+ ionophore. These findings show that concentrative nucleoside transport activity in L1210/AM cells required an inward transmembrane Na+ gradient. Treatment of cells in sodium medium with 2 mM furosemide in the absence or presence of 2 mM ouabain inhibited Na(+)-dependent adenosine transport by 50 and 75%, respectively. However, because treatment of cells with either agent in Na(+)-free medium decreased adenosine transport by only 25%, part of this inhibition may be secondary to the effects of furosemide and ouabain on the ionic content of the cells. Substitution of extracellular Cl- by SO4(-2) or SCN- had no effect on the concentrative influx of adenosine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007583

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Protection against fludarabine neurotoxicity in leukemic mice by the nucleoside transport inhibitor nitrobenzylthioinosine.

Authors:  A A Adjei; L Dagnino; M M Wong; A R Paterson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Nucleoside transport in isolated human and rhesus choroid plexus tissue slices.

Authors:  C B Washington; K M Giacomini; C M Brett
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

3.  Generation of cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate by CD38 for Ca2+ signaling in interleukin-8-treated lymphokine-activated killer cells.

Authors:  So-Young Rah; Mazhar Mushtaq; Tae-Sik Nam; Suhn Hee Kim; Uh-Hyun Kim
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

4.  Nucleoside uptake in rat liver parenchymal cells.

Authors:  J Mercader; M Gomez-Angelats; B del Santo; F J Casado; A Felipe; M Pastor-Anglada
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

5.  Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells.

Authors:  X Fang; F E Parkinson; D A Mowles; J D Young; C E Cass
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

6.  The antimitotic drug 4,6-dimethyl-2-amino-3,4,5- trimethoxyphenyl-pyrimidine inhibits the nucleoside transport system of cells from various animal species.

Authors:  A Pani; P Obino; P Guarracino; P La Colla
Journal:  Experientia       Date:  1994-01-15

7.  Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells.

Authors:  C E Boumah; D L Hogue; C E Cass
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

8.  Differential uptake of [3H]guanosine by nucleoside transporter subtypes in Ehrlich ascites tumour cells.

Authors:  J R Hammond
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

9.  Transport of the anti-varicella-zoster virus agent 6-methoxypurine arabinoside and its 2'-O-valerate prodrug into human erythrocytes.

Authors:  K L Prus; A C Heidenreich; T P Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.